000 01600 a2200409 4500
005 20250517003403.0
264 0 _c20151022
008 201510s 0 0 eng d
022 _a1433-7339
024 7 _a10.1007/s00520-014-2521-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWatkins, Karen R
245 0 0 _aTolerability of denosumab in metastatic solid tumor patients with renal insufficiency.
_h[electronic resource]
260 _bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_cJun 2015
300 _a1657-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadverse effects
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aBone Neoplasms
_xsecondary
650 0 4 _aDenosumab
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypocalcemia
_xchemically induced
650 0 4 _aHypophosphatemia
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms, Second Primary
_xtherapy
650 0 4 _aRenal Insufficiency
_xcomplications
650 0 4 _aRetrospective Studies
700 1 _aRogers, Jane E
700 1 _aAtkinson, Bradley
773 0 _tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_gvol. 23
_gno. 6
_gp. 1657-62
856 4 0 _uhttps://doi.org/10.1007/s00520-014-2521-8
_zAvailable from publisher's website
999 _c24377081
_d24377081